Formic Acid

Formic Acid

SCHEMBL31064289

CNC(=O)C1OCCC1c1ccccc1.O=CO

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ HDAC4 P56524 2/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ SMN1; SMN2 Q16637 1/20 0.37
▸ NPSR1 Q6W5P4 1/20 0.37
▸ HPGD P15428 2/20 0.37
▸ KDM1A O60341 2/20 0.36
▸ KCNQ3 O43525 1/20 0.36
▸ KCNQ2 O43526 1/20 0.36
▸ GAA P10253 3/20 0.36
▸ KDM4E B2RXH2 2/20 0.36
▸ MAPT P10636 2/20 0.36
▸ LMNA P02545 1/20 0.36
▸ ALOX12 P18054 1/20 0.36
▸ CACNA1B Q00975 1/20 0.36
▸ APBA1 Q02410 1/20 0.36
▸ MAOB P27338 1/20 0.35
▸ SLC6A4 P31645 2/20 0.35
▸ SLC6A3 Q01959 2/20 0.35
▸ SLC6A2 P23975 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31191672 0.94 HDAC4 (0.41) HDAC4ALDH1A1SMN1; SMN2NPSR1HPGD
Trifluoroacetic Acid SCHEMBL31703769 0.86 KDM1A (0.40) HDAC4ALDH1A1SMN1; SMN2NPSR1HPGD
SCHEMBL28376946 0.80 AKR1C3 (0.41) HDAC4ALDH1A1SMN1; SMN2NPSR1HPGD
SCHEMBL31703382 0.80 AKR1C3 (0.41) HDAC4ALDH1A1SMN1; SMN2NPSR1HPGD
SCHEMBL31703464 0.79 HDAC4 (0.44) HDAC4ALDH1A1SMN1; SMN2NPSR1HPGD
SCHEMBL31703956 0.73 TSHR (0.60) ALDH1A1SMN1; SMN2MAPTLMNA
SCHEMBL16639029 0.67 HDAC4 (0.71) HDAC4ALDH1A1SMN1; SMN2HPGDGAA
SCHEMBL6339509 0.67 HDAC4 (0.71) HDAC4ALDH1A1SMN1; SMN2HPGDGAA
SCHEMBL31703439 0.67 SLC6A4 (0.40) SLC6A4SLC6A3SLC6A2
SCHEMBL31191667 0.66 GPR88 (0.35) ALDH1A1KDM1AKCNQ3KCNQ2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4676540-A1 PANRAS INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF Novartis AG (CH) 2026-01-14 — — EP disclosed
WO-2024189481-A1 PANRAS INHIBITOR ANTIBODY-DRUG CONJUGATES AND METHODS OF USE THEREOF NOVARTIS AG (CH) 2024-09-19 — — WO disclosed
Send feedback